1st Oct 2019 07:00
Ideagen PLC
("Ideagen," "the Company" or the "Group'')
Exercise of Options, issue of shares and Total Voting Rights
Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces the allotment of 225,000 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following the exercise of 225,000 options by an employee and the allotment of 316,025 new Ordinary shares following the annual award of shares to eligible employees (the "Free Shares") under the Company's Share Incentive Plan ("SIP").
Under the terms of the SIP, the Company makes an annual award of Free Shares to all eligible employees subject to the achievement of a profit target set by the Board for a particular year. The profit target was achieved in respect of the year ended 30 April 2019 and the Company has agreed to award new Ordinary Shares to the value of £2,000 to all eligible employees based on the closing mid-market price on 6 September 2019 (the "Award"). In order to obtain the full tax benefits of the SIP, members of staff will need to remain as employees of the Group for 5 years from the date of the Award.
Accordingly, the Company has allotted a total of 316,025 Ordinary Shares to be held in trust for the benefit of employees.
As part of the Award, 1,342 new Ordinary Shares were allotted to each of the executive directors of the Company; David Hornsby, Ben Dorks, Graeme Spenceley and Barnaby Kent, who now have the following interests in the share capital of the company.
Executive Director | Previous shareholding | New shareholding | % of enlarged issued share capital held |
David Hornsby | 8,650,066 | 8,651,408 | 3.9% |
Ben Dorks | 2,350,533 | 2,351,875 | 1.1% |
Graeme Spenceley | 828,253 | 829,595 | 0.4% |
Barnaby Kent | 2,278,193 | 2,279,535 | 1.0% |
Application has been made for the total of 541,025 new Ordinary Shares issued pursuant to the above allotments, which will rank pari passu with existing Ordinary Shares, to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective and dealings will commence at 8:00am on 4 October 2019.
On Admission, the total number of Ordinary Shares in issue will be 221,359,369 and the total number of voting rights will therefore be 221,359,369. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
Enquiries:
Ideagen plc | 01629 699100 |
David Hornsby, Executive Chairman | |
Ben Dorks, Chief Executive | |
Graeme Spenceley, Finance Director | |
finnCap Limited | 020 7220 0500 |
Henrik Persson/James Thompson (Nomad) | |
Alice Lane (ECM) | |
Canaccord Genuity | 020 7523 8000 |
Simon Bridges | |
Richard Andrews | |
About Ideagen plc
Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).
The Group provides IRM software and services to organisations operating within highly regulated industries such as aviation, banking and finance and life science, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.
With an excellent portfolio of software products including Q-Pulse, Coruson, Pentana Audit and PleaseReview, Ideagen helps its clients reduce costs, improve operational efficiency, strengthen compliance and oversight and anticipate and manage every detail of risk.
Currently, more than 4,700 organisations use Ideagen's products including seven of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.
Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 180 hospitals across the UK and US amongst its client base.
For further information please visit www.ideagen.com
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | David Hornsby | ||||
2. | Reason for the Notification | |||||
a) | Position/status | Executive Chairman | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Ideagen plc | ||||
b) | LEI | 213800KS1MLITOVNYC85 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 1p each | ||||
Identification code | GB00B0CM0C50 | |||||
b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information: ·; Aggregated volume ·; Price |
1,342 ordinary shares of 1p each awarded at 149p per share | ||||
e) | Date of the transaction | 30 September 2019 | ||||
f) | Place of the transaction | London Stock Exchange AIM market (XLON) | ||||
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Graeme Spenceley | ||||
2. | Reason for the Notification | |||||
a) | Position/status | CFO | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Ideagen plc | ||||
b) | LEI | 213800KS1MLITOVNYC85 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 1p each | ||||
Identification code | GB00B0CM0C50 | |||||
b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information: ·; Aggregated volume ·; Price | 1,342 ordinary shares of 1p each awarded at 149p per share | ||||
e) | Date of the transaction | 30 September 2019 | ||||
f) | Place of the transaction | London Stock Exchange AIM market (XLON) | ||||
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Ben Dorks | ||||
2. | Reason for the Notification | |||||
a) | Position/status | CEO | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Ideagen plc | ||||
b) | LEI | 213800KS1MLITOVNYC85 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 1p each | ||||
Identification code | GB00B0CM0C50 | |||||
b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information: ·; Aggregated volume ·; Price | 1,342 ordinary shares of 1p each awarded at 149p per share | ||||
e) | Date of the transaction | 30 September 2019 | ||||
f) | Place of the transaction | London Stock Exchange AIM market (XLON) | ||||
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Barnaby Kent | ||||
2. | Reason for the Notification | |||||
a) | Position/status | Chief Operating Officer | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Ideagen plc | ||||
b) | LEI | 213800KS1MLITOVNYC85 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 1p each | ||||
Identification code | GB00B0CM0C50 | |||||
b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information: ·; Aggregated volume ·; Price |
1,342 ordinary shares of 1p each awarded at 149p per share | ||||
e) | Date of the transaction | 30 September 2019 | ||||
f) | Place of the transaction | London Stock Exchange AIM market (XLON) | ||||
Related Shares:
IDEA.L